Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study

Brain

Volumn 121, Issue 9, 1998, Pages 1631-1639

  Fox, N C ^a,b   Warrington, E K ^a   Seiffer, A L ^a   Agnew, S K ^a   Rossor, Martin N ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; At risk; Familial; Memory; Presymptomatic

Indexed keywords

ADULT; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; TEMPORAL LOBE; VERBAL MEMORY;

ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; INTELLIGENCE TESTS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGICAL TESTS; RISK FACTORS; TIME FACTORS;

EID: 0031707071     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.9.1631     Document Type: Article

References (49)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV. 4th ed. Washington (DC): American Psychiatric Association; 1994.
2. Baxter DM, Warrington EK. Measuring dysgraphia: a graded-difficulty spelling test. Behav Neurol 1994; 7: 107-16.
3. Becker JT, Lopez OL, Wess J. Material-specific memory loss in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992; 55: 1177-81.
4. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349: 763-5.
5. Capitani E, Delia Sala S, Spinnler H. Controversial neuropsychological issues in Alzheimer's disease: influence of onset-age and hemispheric asymmetry of impairment. Cortex 1990; 26: 133-45.
6. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41: 1006-9.
7. Flicker C, Ferris SH, Reisberg B. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol 1993; 6: 84-96.
8. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
9. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease [see comments]. Lancet 1996a; 348: 94-7. Comment in: Lancet 1996; 348: 829-30.
10. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease [see comments]. Lancet 1996a; 348: 94-7. Comment in: Lancet 1996; 348: 829-30.
11. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, Stevens JM, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996b; 119: 2001-7.
12. Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques PK, Collinge J, et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Brain 1997; 120: 491-501.
13. Golomb J, Kluger A, de Leon MJ, Ferns SH, Mittelman M, Cohen J, et al. Hippocampal formation size predicts declining memory performance in normal aging. Neurology 1996; 47: 810-3.
14. Greene JD, Baddeley AD, Hodges JR. Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test. Neuropsychologia 1996; 34: 537-51.
15. Hardy J. Amyloid, the presenilins and Alzheimer's disease. [Review]. Trends Neurosci 1997; 20: 154-9.
16. Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997; 45: 584-9.
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-72.
18. Jackson M, Warrington EK. Arithmetic skills in patients with unilateral cerebral lesions. Cortex 1986; 22: 611-20.
19. Janowsky JS, Carper RA, Kaye JA. Asymmetrical memory decline in normal aging and dementia. Neuropsychologia 1996; 34: 527-35.
20. Jost BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study [see comments]. J Am Geriatr Soc 1995; 43: 1248-55. Comment in: J Am Geriatr Soc 1995; 43: 1314-5, Comment in: J Am Geriatr Soc 1996; 44: 734.
21. Jost BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study [see comments]. J Am Geriatr Soc 1995; 43: 1248-55. Comment in: J Am Geriatr Soc 1995; 43: 1314-5, Comment in: J Am Geriatr Soc 1996; 44: 734.
22. Jost BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study [see comments]. J Am Geriatr Soc 1995; 43: 1248-55. Comment in: J Am Geriatr Soc 1995; 43: 1314-5, Comment in: J Am Geriatr Soc 1996; 44: 734.
23. Kelly CA, Harvey RJ, Cayton H. Drug treatments for Alzheimer's disease [editorial]. BMJ 1997; 314: 693-4.
24. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995a; 186: 17-20.
25. Kennedy AM, Newman SK, Frackowiak RS, Cunningham VJ, Roques P, Stevens J, et al. Chromosome 14 linked familial Alzheimer's disease: a clinico-pathological study of a single pedigree. Brain 1995b; 118: 185-205.
26. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995; 52: 485-90.
27. Loewenstein D, Barker WW, Chang JY, Apicella A, Yoshii F, Kothari P, et al. Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol 1989; 46: 146-52.
28. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons [see comments]. Neurology 1994; 44: 1427-32. Comment in: Neurology 1995; 45: 2112-3.
29. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons [see comments]. Neurology 1994; 44: 1427-32. Comment in: Neurology 1995; 45: 2112-3.
30. McKenna P, Warrington EK. The Graded Naming Test. Windsor (UK): NFER-Nelson; 1983.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
32. Medical Research Council Report from the MRC Alzheimer's Disease Workshop. London: HMSO; 1986.
33. Nelson HE. The National Adult Reading Test (NART) manual. Windsor: NFER-Nelson,1991.
34. Newman SK, Warrington EK, Kennedy AM, Rossor MN. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J Neurol Neurosurg Psychiatry 1994; 57: 967-72.
35. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E [see comments]. N Engl J Med 1996; 334: 752-8. Comment in: N Engl J Med 1996; 334: 792-4, Comment in: N Engl J Med 1996; 335: 207-8.
36. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E [see comments]. N Engl J Med 1996; 334: 752-8. Comment in: N Engl J Med 1996; 334: 792-4, Comment in: N Engl J Med 1996; 335: 207-8.
37. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E [see comments]. N Engl J Med 1996; 334: 752-8. Comment in: N Engl J Med 1996; 334: 792-4, Comment in: N Engl J Med 1996; 335: 207-8.
38. Rossor M. Alzheimer's disease. [Review]. BMJ 1993; 307: 779-82.
39. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 1982; 105: 313-30.
40. Smith AD, Jobst KA. Use of structural imaging to study the progression of Alzheimer's disease. B Med Bull 1996; 52: 575-86.
41. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Arch Neurol 1989; 46: 383-6.
42. Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, et al. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome [see comments]. Nat Med 1996; 2: 93-5. Comment in: Nat Med 1996; 2: 31-2.
43. Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, et al. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome [see comments]. Nat Med 1996; 2: 93-5. Comment in: Nat Med 1996; 2: 31-2.
44. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996; 46: 661-5.
45. van Duijn CM, Hofman A. Risk factors for Alzheimer's disease: the EURODEM collaborative re-analysis of case-control studies. Neuroepidemiology 1992; 11 Suppl 1: 106-13.
46. Warringtoti EK. Recognition Memory Test Manual. Windsor (UK): NFER-Nelson; 1984.
47. Warrington EK, James M The Visual Object and Space Perception Battery. Bury St Edmunds (UK): Thames Valley Test Co.; 1991.
48. Warrington EK, James M, Maciejewski C. The WAIS as a lateralizing and localizing diagnostic instrument: a study of 656 patients with unilateral cerebral lesions. Neuropsychologia 1986; 24: 223-39.
49. Willison JR, Warrington EK. Cognitive retardation in a patient with preservation of psychomotor speed. Behav Neurol 1992; 5: 113-6.